Odisha Fights COVID-19: Will Plasma Therapy Be The Way Forward? Doctors Here Are Optimistic
Cuttack: In what may be considered as a major breakthrough in treatment of persons afflicted by novel Coronavirus, the first patient in Odisha who underwent Convalescent plasma therapy recovered at Ashwini Hospital in Cuttack. While, nothing concrete has come to the fore, as to whether plasma therapy is the way forward in COVID treatment, doctors in Odisha are optimistic of its results.
Ashwini Hospital Chairman, Dr Subrat Jena said that in several cases, the health of COVID-19 patients is not improving with the routine therapy with medicines and in some cases they develop complications. “For such patients the Convalescent plasma therapy is a major option for treatment. Plasma therapy is going to be the way forward in COVID treatment.”
The first patient who was administered plasma therapy in Odisha at Ashwini COVID Hospital recovered today. A 48-year-old woman from Rousapatna area in Cuttack, was admitted on July 15. “We are very hopeful about the positive results of this treatment. We are thankful to Chief Minister who took this initiative and Odisha became the third State in the country to start Convalescent plasma therapy,” he said.
“The Chief Minister encouraged us to use the therapy. ICMR also has a role in approving the treatment for COVID patients. I am happy with my team of doctors who have worked tirelessly to make this treatment successful,” Dr Jena said.
The woman who recovered today was suffering from COVID pneumonia. “In medical terms we rate this condition as ‘moderately severe’. Such cases are appropriate for administering plasma therapy. But there are conditions and case selection is an important factor here. There are reactions during blood tranfusion, so plasma therapy might also lead to reactions. The doctors need to be careful,” Dr Jena added.
A person who is fit and has good immunity can donate plasma. The plasma transfusion process and the later stage should be monitored very carefully. Besides, the case selection is an important component in success of the Convalescent plasma therapy, he added. “Such cases (recovery with plasma therapy) boost our confidence to implement it on more patients,” Dr Jena said.
Plasma is needed by COVID hospitals for treatment of coronavirus patients. Donation, collection and distribution is being carried out by the nodal centre at a good pace. “The results that we got from this pilot project are very satisfying and at par with our expectations,” he added.